Pune, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Nucleotide Market Size & Growth Analysis:
“According to SNS Insider, The Nucleotide Market Size was valued at USD 0.83 Billion in 2023 and is expected to reach USD 1.61 Billion by 2032 and grow at a CAGR of 8.01% over the forecast period 2024-2032.”
Increased application of nucleotide in nutraceutical products due to unhealthy diets or stress and more use would make the human immune system function well, which is anticipated industry growth. Additionally, expanding pressure from different well-being and security associations concerning human health and well-being is relied upon to encourage product demand over the projected time frame.
Apart from the increase in demand for nucleotides in the pharmaceutical industry, there is also a growing trend to consume adequate dietary sources of nucleotides by consumers across food and animal feed industries. Food and animal feed is added to nucleotides to strengthen immunity and growth-development as a flavor enhancer. Animal protein production is projected to increase at an even faster rate; meat will roughly double, dairy triple and the global fish catch almost treble in size (UN Food & Agricultural Organization [FAO]) making projections for a 60% growth of food by better management on our way towards 2050.
Get a Sample Report of Nucleotide Market@ https://www.snsinsider.com/sample-request/4002
Major Players Analysis Listed in this Report are:
- CJ CheilJedang Corp.
- Agilent Technologies Inc.
- Star Lake Bioscience Co., Inc.
- DSM Nutritional Products AG
- Thermo Fisher Scientific Inc.
- F. Hoffmann-La Roche Ltd.
- MEIHUA HOLDINGS GROUP CO., LTD.
- Biorigin
- Promega Corporation
- Lallemand Inc.
- NuEra Nutraceuticals Inc.
- Other Players
Nucleotide Market Report Scope:
| Report Attributes | Details |
| Market Size in 2023 | US$ 0.83 Billion |
| Market Size by 2032 | US$ 1.61 Billion |
| CAGR | CAGR of 8.01% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Key Growth Drivers | •The Continuous Advancements in Genomic Research and Personalized Medicine Are a Significant Driver for The Nucleotide Market. •The Increasing Prevalence of Genetic Disorders and Chronic Diseases Drives the Demand for Nucleotides Used in Diagnostics and Therapeutics. |
Segmentation Dynamics
The molecular laboratory's prominent method of technology includes TaqMan allelic discrimination, gene and microarrays, and SNP by pyrosequencing, etc. TaqMan allelic discrimination segment has the highest market share of 36% in 2023, which was followed by SNP by pyrosequencing. The TaqMan allelic is likely to grow at a significant rate over the near future primarily on the back of increasing demand from diagnostic research institutes.
Further, demand for TaqMan allelic discrimination technology in the Asia Pacific region is expected to witness significant growth due to the increasing number of chronic diseases. The SNP by pyrosequencing technology is anticipated to experience steady growth during the projection period as it finds extensive application in leading sectors and numerous advantages such as true sequence information easy reading, and sharing.
Do you have any specific queries or need any customization research/data on Nucleotide Market, Enquire Now@ https://www.snsinsider.com/enquiry/4002
Nucleotide Market Key Segmentation:
By Product
- Deoxy Nucleotides
- Dideoxy nucleotides
- Nucleotides for RNA Synthesis (rNTP)
- Others
By Technology
- TaqMan Allelic Discrimination
- Gene Chips & Microarrays
- SNP By Pyrosequencing
- Other
By Application
- Pharmaceuticals
- Diagnostics Research
- Food & Beverage Additive
- Animal Feed Additive
- Others
Regional Insights
Nucleotides Market in North America was the largest, in 2023 it accounted for over 40% of global revenue share. With an increasing focus from regional consumers towards nutritional food products, the region is expected to lead in terms of consumption through the forecast period. Furthermore, the growing practice of self-medication along with increasing health safety awareness is expected to drive growth over the forecast period.
Following North America, Europe accounted for the second largest revenue share of 25% on the global market in 2023 because chemicals have been highly utilized by the regional pharmaceutical sector for the last few years. Increasing application scope in nutraceutical products which aids in enhancing the immune system of animals and humans, is expected to drive nucleotide demand.
Regional Coverage:
• North America (US, Canada, Mexico)
• Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe])
• Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific)
• Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East])
• Africa [Nigeria, South Africa, Rest of Africa]
• Latin America (Brazil, Argentina, Colombia Rest of Latin America)
Recent Developments
- In January 2023, Thermo Fisher Scientific Inc. announced it had finalized its acquisition of The Bonding Site Group ('The Binding Site') from an investor group led by European private equity firm Nordic Capital.
- In March 2020, ADM unveiled NutriNucleus, a new line of nucleotide-based ingredients. It is infused into infant formula, sports nutrition, and other food beverage applications to enhance taste and nutritional features.
Key Takeaways
- TaqMan Allelic Discrimination contributed the highest market share of 36% in 2023 and growing with a high CAGR Supported by increasing demand from diagnostic research institutes.
- Increased health safety awareness, focus on nutritional food products and self-medication are some factors leading to the growth in the North America region.
- Rising consumption of nucleotides in nutraceuticals due to poor dietary habits and hectic lifestyles is expected to fuel industry growth. Use of nucleotides to reinforce the human immune system.
Buy a Single-User PDF of Nucleotide Market Analysis & Outlook Report 2024-2032@ https://www.snsinsider.com/checkout/4002
Table of Contents – Major Key Points
1. Introduction
2. Industry Flowchart
3. Research Methodology
4. Market Dynamics
5. Porter’s 5 Forces Model
6. Pest Analysis
7. Nucleotide Market Segmentation, By Product
8. Nucleotide Market Segmentation, By Technology
9. Nucleotide Market Segmentation, By Application
10. Regional Analysis
11. Company Profiles
12. Competitive Landscape
13. Use Case and Best Practices
14. Conclusion
Access Complete Report Details of Nucleotide Market Analysis & Outlook 2024-2032@ https://www.snsinsider.com/reports/nucleotide-market-4002
[For more information or need any customization research mail us at info@snsinsider.com]
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
